Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
|
Daily Overview |
| Session | |
|
CP13: Ticks, Mites, kissing bugs 10 min talks Location: Lecture Theatre 3 Session Chair: Katja Fischer, QIMR Berghofer Session Chair: Xavier Barton, Murdoch University | |
| Presentation 3 | |
Life-stage resolved microbiota of Sarcoptes scabiei reveals a stable core bacterial community comprised of opportunistic pathogens Infection and Inflammation program, QIMR Berghofer, Brisbane, Australia Scabies is a neglected tropical disease affecting approximately 400 million people globally. The obligate lifecycle of Sarcoptes scabiei has limited our understanding of its biology, largely due to difficulties in maintaining the parasite outside its host. The development of an ex-vivo culture system has facilitated improved investigation of the mite’s complex biology. With the known prevalence of symbionts amongst haematophagous arthropods and the strong association with secondary bacterial infections, this study has attempted to provide the first life-stage specific microbiota and to identify core components of the S. scabiei microbiota. Over 48,000 individual parasites were collected across five key life-stages (eggs, larvae, nymphs, males and females). 16S full-length rRNA amplicon sequencing was performed on the PacBio platform. A total of 3,500,187 reads and 487 amplicon sequence variants (ASVs) were identified. The genera Corynebacterium, Serratia and Acinetobacter were present across all life-stages with the opportunistic pathogens Acinetobacter baumannii and Serratia marcescens identified as key constituents of the scabies microbiome. This study provides the first evidence of a stable core microbiota across all life stages of S. scabiei, offering new insights that could improve understanding of mite biology and management of scabies and associated secondary bacterial infections. | |
